Canada· CA-DIN-02242504
BUTORPHANOL NASAL SPRAY
A butorphanol product containing butorphanol tartrate, registered in Canada by AA PHARMA INC. The same ATC class is registered in 2 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Butorphanol is registered in 2 of 19 countries.
Countries holding a registration under ATC N02AF01 (butorphanol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Butorphanol · ATC N02AF01
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- BUTORPHANOL TARTRATE
- Manufacturer
- AA PHARMA INC
- Country
- Canada (CA)
- ATC code
- N02AF01
- ATC class
- Butorphanol
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for butorphanol.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Butorphanol · interactions on record
203 records
- 51 severe
- 113 moderate
- 39 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- AprepitantA04AD12severe
- AlvimopanA06AH02severe
- OpiumA07DA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Butorphanol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3563b6c-9cd7-4670-b094-36242451c5f1 GET /v1/drugs/a3563b6c-9cd7-4670-b094-36242451c5f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02242504",
"form": "SOLUTION",
"class": "Human",
"routes": [
"NASAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N02AF01",
"schedule": [
"Schedule G (CDSA IV)"
],
"drug_code": "66247",
"strengths": [
"10 MG"
],
"ahfs_class": null,
"substances": [
"BUTORPHANOL TARTRATE"
],
"product_categorization": null
}See everything about butorphanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.